Back to CVE records
Medium 4.8Published Oct 16, 2026

CVE-2026-111212ImprintLab Medical-SAM-Adapter AutoBackend Model Loading autobackend.py session.get_modelmeta.custom_metadata_map eval injection

Updated under an hour ago ()

Does this affect you?

It affects ImprintLab Medical-SAM-Adapter. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A security flaw has been discovered in ImprintLab Medical-SAM-Adapter 0.1.0-alpha/0.1.0. Affected by this issue is the function session.get_modelmeta.custom_metadata_map of the file models/MobileSAMv2/ultralytics/nn/autobackend.py of the component AutoBackend Model Loading. The manipulation of the argument imgsz/names/kpt_shape results in improper neutralization of directives in dynamically evaluated code. The attack requires a local approach. The exploit has been released to the public and may be used for attacks. The project was informed of the problem early through an issue report but has not responded yet.

CVSS
4.8 MEDIUM (v3.1, CNA)CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:L/I:L/A:L/E:P/RL:X/RC:C
Weakness (CWE)
CWE-95, CWE-94
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
VulDB
NVD analysis
Deferred
Record last updated
Oct 16, 2026
First seen by InfoSec Signals
Oct 16, 2026

Affected products

Affected products
ImprintLab Medical-SAM-Adapter
imprintlab:medical-sam-adapter
0.1.0; 0.1.0-alpha
CNA record

References

  • vdb-entry, technical-description
  • signature, permissions-required
  • third-party-advisory
  • third-party-advisory
  • exploit, issue-tracking
  • product

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.